newsfilter
← Latest News
Earnings Call Transcripts·

STEPHENS ANNUAL INVESTMENT CONFERENCE | NASH2026 - ADDUS HOMECARE CORP

  • Financial Performance:

    • 2026 delivered strong financial performance across all three lines of business (Personal Care, Home Health, Hospice) with no significant negative impact from OB3 or Medicaid work requirements.
    • The AccentCare transaction, expected to close in Q1 2027 (February), will add approximately $280 million in annual revenue.
    • Upon closing AccentCare, the company expects to remain levered at only 1.0x, maintaining significant debt capacity for future transactions.
    • Current leverage remains clean, preserving flexibility for larger clinical acquisitions.
    • Same-store revenue growth for Home Health is showing positive momentum for the first time in several quarters, despite being a small division.
    • Hospice segment is growing at high single-digit organic rates with stable admission counts and average length of stay (ALOS) above 100 days.
  • Guidance and Future Outlook:

    • Management anticipates 2027 to be another strong year driven by incremental improvements, acquisition integration, and favorable regulatory environments.
    • Long-term organic growth targets are set at 3-5% annually.
    • Home Health growth is expected to reach mid-single digits long-term, contingent on the 2.4% national rate increase and volume recovery.
    • Management aims to increase the clinical services portion of the business from the current ~18% back to 25-30%.
    • Full integration of the "Home Care Home Base" technology platform is targeted for completion by the end of 2027 (excluding post-AccentCare integration timelines).
    • Personal Care fill rates are projected to move from mid-80s to upper-80s over the next 12-18 months via technology-driven scheduling efficiency.
  • Business Segments and Product Lines:

    • Personal Care Services (PCS): The core engine of the business; leveraged for data collection to drive referrals to higher-level clinical care. The "Addis Connect" app in IL and TX has successfully increased caregiver shift uptake and fill rates.
    • Home Health: Successfully reoriented leadership and sales teams; moving from a cost-reduction mode to a growth-focused mode with a focus on episodic reimbursement contracts.
    • Hospice: Operating at ~180% of prior market capacity; stable ALOS with management focused on staffing efficiency (nurse-to-patient ratios) to maintain margins.
    • Strategic Focus: A "bridge program" strategy utilizes non-clinical PCS staff as the first line of defense to identify care needs and transition patients to Home Health or Hospice, reducing hospital readmissions.
    • M&A Pipeline: Actively pursuing 2-3 clinical acquisitions in 2027, including PCS transactions and potential clinical services additions, following the closing of the AccentCare deal.
  • Market and Competitive Landscape:

    • Regulatory Environment: Improved outlook following the 2024 elections; Democratic leadership expected to support Medicaid funding and potentially defer work requirements.
    • Market Dynamics: Texas transitioned from Republican to Democratic control, presenting new opportunities for rate increases despite previous Republican administrations having provided raises.
    • Competition: New entrants in Illinois are generally small-scale (10-20 patients); Addis focuses on capturing larger volume patients (50-70 hours/month) rather than low-volume respite care.
    • Reimbursement: Favorable 2.4% national rate increase finalized for Home Health; Hospice consistently receiving 2-3% CMS rate hikes.
    • Managed Care: In New Mexico, MCOs prioritize provider density and coverage ability over caregiver supply, favoring large integrated providers like Addis.
  • Risks and Challenges:

    • Staffing & Turnover: Personal Care industry turnover averages 65% (Addis at 50%); growth is constrained by the ability to onboard 103-110 new hires per business day to maintain volume.
    • Overtime Costs: Operational profitability is sensitive to overtime; the strategy focuses on maximizing regular hour placement to avoid the financial penalty of overtime.
    • Census Softness: Minor seasonal and census softness observed in Illinois and Texas during Q3/Q4 due to holiday authorization delays and state-specific dynamics, though expected to rebound.
    • Valuation: M&A multiples for pure-play hospice have historically been mid-teens (too high); opportunities are emerging in the lower double-digit range or smaller single-digit deals as market prices rationalize.
  • Management Commentary and Tone:

    • Management expressed high confidence in 2026 results, citing a "good year" despite initial industry concerns regarding OB3.
    • CEO Dirk Allison and CFO Brian Poth highlighted the strategic advantage of their three-tier service model (PCS, Home Health, Hospice) for value-based care and payer relationships.
    • The tone regarding the future is optimistic, emphasizing the completion of the AccentCare integration and the readiness for new clinical acquisitions.
    • Management views the "bridge program" leveraging PCS data as the most underappreciated driver of long-term earnings power, alongside technology-driven fill rate optimization.
  • Analyst Questions and Answers:

    • Q: Impact of OB3 work requirements? A: No negative impact observed in Montana; no influx of patients entering the workforce, suggesting the policy has not materially altered demand or supply dynamics for the company.
    • Q: M&A execution in 2027? A: AccentCare (Antitrust cleared) closes Feb 2027; 2-3 additional clinical/PCS deals identified. Goal is to increase clinical mix to 25-30%.
    • Q: Personal Care fill rate strategy? A: Shift from staffing-centric to technology-centric via "Addis Connect" app to match caregiver availability with authorized hours, targeting upper-80s fill rates.
    • Q: Census trends in Q4? A: Anticipated slight month-over-month slowdown in Nov/Dec due to holiday authorization delays, but year-over-year growth is expected; focus remains on converting authorized hours into billable hours.
    • Q: Home Health margin/growth outlook? A: Margins stabilizing; volume growth expected to turn positive due to 2.4% rate increase and successful sales team restructuring.
    • Q: Payer relationships in Managed Care? A: MCOs in NM value density and coverage breadth; Addis's scale allows it to serve dispersed populations better than fragmented competitors.
  • Other Key Points:

    • Technology Integration: Transitioning all Personal Care systems to "Home Care Home Base" by end of 2027 will unify data and scheduling across the organization.
    • Clinical Services Strategy: Moving beyond just Personal Care to actively recruit clinical services (RNs, etc.) to support the bridge program and improve value-based care outcomes.
    • Market Share: Already a sizable provider in Hospice (180%+ capacity); focusing on efficiency to maintain margins while growing.
    • Geographic Focus: Core operations concentrated in Illinois, Texas, and New Mexico, with a strategy to expand leverage in these primary states before broader geographic rollout.
Company
ADDUS HOMECARE CORP
Keywords
ADDUS HOMECARE CORP